Because numerous JAK1 and JAK3 variants associated with hematological malignancies are located within dynamic structural loops (Figure 2), it is conceivable that these regions may be more susceptible to allosteric drug-targeting. This evidence concerns the gene JAK1 and hematologic disorder.